Canada markets closed

Agile Therapeutics, Inc. (AGRX)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
0.2680-0.0070 (-2.55%)
At close: 04:00PM EST
0.2782 +0.01 (+3.81%)
After hours: 07:56PM EST
Currency in USD

Valuation Measures4

Market Cap (intraday) N/A
Enterprise Value N/A
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)N/A
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA N/A

Trading Information

Stock Price History

Beta (5Y Monthly) 1.01
52-Week Change 3-98.04%
S&P500 52-Week Change 3-7.75%
52 Week High 315.2000
52 Week Low 30.1750
50-Day Moving Average 30.2351
200-Day Moving Average 30.7483

Share Statistics

Avg Vol (3 month) 3910.12k
Avg Vol (10 day) 31.01M
Shares Outstanding 540.61M
Implied Shares Outstanding 6N/A
Float 837.41M
% Held by Insiders 17.84%
% Held by Institutions 15.72%
Shares Short (Jan 12, 2023) 4682.63k
Short Ratio (Jan 12, 2023) 40.78
Short % of Float (Jan 12, 2023) 41.68%
Short % of Shares Outstanding (Jan 12, 2023) 41.68%
Shares Short (prior month Dec 14, 2022) 4684.13k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:40
Last Split Date 3Apr 26, 2022

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2021
Most Recent Quarter (mrq)Sept 29, 2022


Profit Margin 0.00%
Operating Margin (ttm)-677.39%

Management Effectiveness

Return on Assets (ttm)-129.01%
Return on Equity (ttm)-791.13%

Income Statement

Revenue (ttm)8.4M
Revenue Per Share (ttm)0.70
Quarterly Revenue Growth (yoy)133.30%
Gross Profit (ttm)-6.62M
Net Income Avi to Common (ttm)-67.01M
Diluted EPS (ttm)-26.1610
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)6.14M
Total Cash Per Share (mrq)0.15
Total Debt (mrq)2.15M
Total Debt/Equity (mrq)34.26
Current Ratio (mrq)1.33
Book Value Per Share (mrq)0.16

Cash Flow Statement

Operating Cash Flow (ttm)-51.01M
Levered Free Cash Flow (ttm)-34.63M